Get the Stockscreener App
118.80
1.67%
-2.02
After Hours:
118.80
Overview
News
Price History
Option Chain
Financials
Why ZTS Down?
Discussions
Forecast
Dividend History
Zoetis Inc stock is traded at $118.80, with a volume of 4.61M.
It is down -1.67% in the last 24 hours and down -17.53% over the past month.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
See More
Previous Close:
$120.82
Open:
$120.71
24h Volume:
4.61M
Relative Volume:
1.43
Market Cap:
$53.24B
Revenue:
$9.40B
Net Income/Loss:
$2.65B
P/E Ratio:
20.02
EPS:
5.935
Net Cash Flow:
$2.24B
1W Performance:
-0.83%
1M Performance:
-17.53%
6M Performance:
-27.13%
1Y Performance:
-32.17%
1-Day Range:
$118.35
$121.09
1-Week Range:
$118.35
$122.96
52-Week Range:
$117.26
$181.85
Zoetis Inc Stock (ZTS) Company Profile
Compare ZTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
118.80 | 53.24B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.14 | 45.14B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.68 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
VTRS
Viatris Inc
|
10.66 | 12.35B | 14.33B | -3.79B | 1.84B | -3.17 |
|
UTHR
United Therapeutics Corp
|
471.92 | 20.08B | 3.08B | 1.24B | 1.07B | 25.61 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jun-18-25 | Downgrade | Stifel | Buy → Hold |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-12-24 | Reiterated | Stifel | Buy |
| Dec-19-23 | Resumed | Jefferies | Buy |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-08-21 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-08-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Sep-21-20 | Initiated | Atlantic Equities | Overweight |
| Aug-14-20 | Upgrade | Edward Jones | Hold → Buy |
| Aug-12-20 | Downgrade | Gabelli & Co | Buy → Hold |
| May-27-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Sep-09-19 | Initiated | Goldman | Buy |
| Jul-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-11-19 | Initiated | Barclays | Overweight |
| May-23-19 | Initiated | Guggenheim | Buy |
| May-03-19 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-20-19 | Initiated | SunTrust | Hold |
| Mar-04-19 | Upgrade | Stifel | Hold → Buy |
| Jan-23-19 | Initiated | UBS | Neutral |
| Oct-15-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-22-18 | Downgrade | Stifel | Buy → Hold |
| Aug-03-18 | Reiterated | Stifel | Buy |
| Apr-19-18 | Reiterated | Citigroup | Buy |
| Mar-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-16-18 | Reiterated | Stifel | Buy |
| Jan-04-18 | Upgrade | Citigroup | Neutral → Buy |
View All
Zoetis Inc Stock (ZTS) Latest News
Candlestick signals on Zoetis Inc. stock todayJuly 2025 Final Week & Accurate Buy Signal Alerts - newser.com
How supply shortages influence Zoetis Inc. Class stockWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com
What momentum shifts mean for Zoetis Inc.July 2025 Summary & Proven Capital Preservation Tips - newser.com
Can Zoetis Inc. stock hit record highs againBear Alert & Low Risk High Win Rate Stock Picks - newser.com
Why Zoetis Inc. Class stock is a strong analyst pickJuly 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
Zoetis Inc. (NYSE:ZTS) Shares Could Be 32% Below Their Intrinsic Value Estimate - Yahoo Finance
Is Zoetis Inc. Class stock a buy on weaknessPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Is Zoetis Inc. meeting your algorithmic filter criteriaJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
How big funds are accumulating Zoetis Inc. Class stockEarnings Overview Report & Weekly Watchlist of Top Performers - newser.com
Can Zoetis Inc. Class stock deliver double digit returnsJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - newser.com
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore - Finviz
Published on: 2025-11-14 12:34:26 - newser.com
Intraday pattern recognizer results for Zoetis Inc.2025 Trading Recap & Growth Focused Entry Reports - newser.com
Zoetis: A High-Quality Compounder Now On Sale? - Forbes
Is Zoetis Inc. stock recession proofJuly 2025 Pullbacks & Accurate Buy Signal Alerts - Fundação Cultural do Pará
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up - AOL.com
Is Zoetis Inc. (ZOE) stock a buy before earnings resultsProfit Target & Technical Pattern Based Signals - newser.com
Is Zoetis Inc. Class stock cheap by valuation metricsJuly 2025 Snapshot & Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-11-13 12:21:40 - newser.com
Zoetis agreed diagnostic firm deal - Vet Times
Zoetis Inc Stock (ZTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):